We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Enterprise-Grade Digital Stethoscope Platform Brings Non-Invasive Heart Disease Detection to Primary Care

By HospiMedica International staff writers
Posted on 28 Feb 2023

Valvular heart disease (VHD) can be life-threatening if left undiagnosed and untreated, resulting in heart failure, stroke, blood clots, and death. More...

Adults over the age of 65 have a one in ten chance of developing clinically significant VHD, yet more than half (57%) of these cases go undetected. Now, a cardiovascular disease detection platform combines the latest advancements in applied machine learning with one of the most ubiquitous medical devices in the world: the stethoscope to objectively identify structural murmurs, a sign of VHD.

Eko (Oakland, CA, USA) has unveiled the SENSORA Cardiac Disease Detection Platform, which uses artificial intelligence to identify structural murmurs, as well as Care Pathway Analytics software to provide visibility and metrics of the patient's progress through the healthcare system. Eko achieved this by capturing and analyzing heart sounds and electrical signals with its digital stethoscopes. The use of this detection platform is set to expand further as the company develops applications for other cardiac issues.

The SENSORA FDA-cleared structural murmur detection helps health systems accurately and consistently identify VHD in patients during a routine visit to a primary care physician. When a primary care physician uses this platform for structural murmur detection, their likelihood of detecting a significant VHD in an older patient more than doubles. Additionally, SENSORA's Care Pathway Analytics allows for better follow up with patients identified with structural murmurs, offering downstream visibility into patient flows, clinical outcomes, and patient economics. By assisting with key decision-making, such as identifying care gaps, SENSORA helps to improve operational efficiencies, reduce delays in delivery of care, reduce the length of stay, lower readmission rates, and increase patient and physician satisfaction.

"Our vision for SENSORA is to make cardiovascular disease detection simple and accurate in frontline care settings like primary care and urgent care," said Connor Landgraf, Co-founder & CEO of Eko. "During a routine physical exam, patients can now have access to advanced structural murmur detection and arrhythmia assessment by their primary care physician in seconds, making early intervention possible for millions of patients with silent cardiovascular disease. We are making the world's most universal medical exam objective and accurate."

Related Links:
Eko 


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
12-Channel ECG
CM1200B
New
Critical Care Cart
Avalo
New
Pedicle Screw Platform
CREO DLX Stabilization System
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The engine-free, nonlinear, flexible, micro-robotic platform leverages AI to optimize GBM treatment (Photo courtesy of Symphony Robotics)

First-Ever MRI-Steerable Micro-Robotics to Revolutionize Glioblastoma Treatment

Glioblastoma Multiforme (GBM) is one of the most aggressive and difficult-to-treat brain cancers. Traditional surgical procedures, such as craniotomies, involve significant invasiveness, requiring large... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.